David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$408M |
| 2 |
Medtronic
MDT
|
+$271M |
| 3 |
NXP Semiconductors
NXPI
|
+$270M |
| 4 |
Gilead Sciences
GILD
|
+$253M |
| 5 |
Hewlett Packard
HPE
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$424M |
| 2 |
CVS Health
CVS
|
+$391M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
+$323M |
| 4 |
Wells Fargo
WFC
|
+$280M |
| 5 |
VMW
VMware, Inc
VMW
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 10.41% |
| 3 | Financials | 9.12% |
| 4 | Communication Services | 8.45% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1901
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.18M | ﹤0.01% |
49,000
+40,000
| +444% | +$1.41M |
|
|
EGIO
1902
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.18M | ﹤0.01% |
21,588
+528
| +3% | +$44.8K |
|
|
SCMP
1903
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $2.18M | ﹤0.01% |
160,559
+58,058
| +57% | +$810K |
|
1904
PUT
Credit Acceptance
CACC
$6.27B
| $2.17M | ﹤0.01% |
+10,000
| New | +$1.94M |
|
1905
Curis
CRIS
$3.86M
| $2.17M | ﹤0.01% |
353
+107
| +43% | +$643K |
|
1906
Applied Optoelectronics
AAOI
$9.61B
| $2.17M | ﹤0.01% |
92,658
-6,018
| -6% | -$139K |
|
1907
McGrath RentCorp
MGRC
$2.8B
| $2.17M | ﹤0.01% |
55,370
+16,715
| +43% | +$583K |
|
1908
Becton Dickinson
BDX
$51.7B
| $2.17M | ﹤0.01% |
+13,413
| New | +$2.23M |
|
|
WLL
1909
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $2.16M | ﹤0.01% |
600
+500
| +500% | +$1.5M |
|
1910
Santander
BSBR
$43.4B
| $2.16M | ﹤0.01% |
253,913
+83,885
| +49% | +$630K |
|
1911
Clarus
CLAR
$145M
| $2.16M | ﹤0.01% |
405,590
-4,624
| -1% | -$25.8K |
|
|
BBBY
1912
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.16M | ﹤0.01% |
53,104
+5,027
| +10% | +$218K |
|
|
PDS
1913
Precision Drilling
PDS
$1.12B
| $2.16M | ﹤0.01% |
+19,791
| New | +$1.95M |
|
1914
Texas Capital Bancshares
TCBI
$4.29B
| $2.15M | ﹤0.01% |
27,432
-16,691
| -38% | -$1.13M |
|
|
CRCM
1915
DELISTED
CARE.COM, INC.
CRCM
| $2.14M | ﹤0.01% |
250,248
+37,104
| +17% | +$326K |
|
|
EA
1916
CALL
DELISTED
Electronic Arts
EA
| $2.14M | ﹤0.01% |
+27,200
| New | +$2.19M |
|
|
SRCL
1917
DELISTED
Stericycle Inc
SRCL
| $2.14M | ﹤0.01% |
27,780
+14,078
| +103% | +$1.06M |
|
|
HZN
1918
DELISTED
Horizon Global Corporation
HZN
| $2.14M | ﹤0.01% |
89,068
-8,252
| -8% | -$186K |
|
1919
Heritage Financial
HFWA
$1.18B
| $2.12M | ﹤0.01% |
82,487
+32,560
| +65% | +$696K |
|
1920
iShares Biotechnology ETF
IBB
$10.9B
| $2.12M | ﹤0.01% |
+24,000
| New | +$2.18M |
|
|
MJN
1921
PUT
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.12M | ﹤0.01% |
30,000
| – | – |
|
|
CLDT
1922
Chatham Lodging
CLDT
$642M
| $2.12M | ﹤0.01% |
103,283
+34,220
| +50% | +$658K |
|
1923
Core Laboratories
CLB
$553M
| $2.12M | ﹤0.01% |
17,664
-5,536
| -24% | -$613K |
|
1924
Foster
FSTR
$401M
| $2.12M | ﹤0.01% |
155,502
-11,088
| -7% | -$144K |
|
1925
PUT
Lam Research
LRCX
$394B
| $2.12M | ﹤0.01% |
200,000
| – | – |
|
Similar funds
David Shaw's Q4 2016 Portfolio in Review
As of Q4 2016, David Shaw held 3,804 positions worth $58.9B, up 3.9% from $56.7B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
David Shaw's Q4 2016 filing shows 462 new, 1,382 increased, 1,255 reduced and 397 closed positions. Its largest new stake was Deere & Co: 1,429,259 shares worth $147M. The largest sale was Amazon, an estimated $424M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2016 buy was Deere & Co: 1,429,259 shares worth $147M.
- David Shaw added most to Netflix in Q4 2016, an estimated $408M increase.
- David Shaw's biggest Q4 2016 reduction was Amazon, cutting an estimated $424M.
- David Shaw fully exited LinkedIn Corporation in Q4 2016, selling an estimated $323M.
- David Shaw's ten largest holdings make up 8.8% of its $58.9B portfolio in Q4 2016.
- David Shaw opened 462 new positions and closed 397 in Q4 2016.
- David Shaw's portfolio value rose 3.9% quarter-over-quarter to $58.9B.
Based on D.E. Shaw & Co's 13F filing for Q4 2016, filed 14 Feb 2017.